In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  ziv-aflibercept
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-1207, 2012-002317-18, NCT01646554

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AFLIBC06097, 2011-005724-17, U1111-1125-8949, NCT01571284

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AFLIBL06266, 2012-000048-89, U1111-1128-9325, NCT01670721

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC11338, U1111-1115-7227, NCT01661270

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Pro00037688, NCT01661972

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AFLIBC06561, 2013-000858-22, U1111-1143-3015, NCT01955629

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00559, ECOG-E4805, CDR0000489069, E4805, U10CA021115, NCT00357760

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00180, PHII-73, N01CM62209, CDR0000558101, CCC-PHII-73, 7518, NCT00509249

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 16
Sponsor: NCI
Protocol IDs: NCI-2011-02498, N01CM00038, CHNMC-PHII-107, CDR0000690654, PHII-107, 8628, N01CM62209, P30CA033572, NCT01258855

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSU 11182, NCI-2012-01167, NCT01652196

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BrUOG C261, NCT01669720

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-401, NCT01747551

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI GI 168, NCT01749956

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-456, NCT01782443

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VELVET C12-1, 2012-003521-25, NCT01802684

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC11885, U1111-1120-0173, NCT01882868

17.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NSABP FC-8, NCT01889680

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: Q-CROC-04, NCT02045030

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: Over 18
Sponsor: Other
Protocol IDs: 1309014302, 2012-AFL-18, NCT02046538

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-145, NCT02079220

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LPS13787, U1111-1149-0237, NCT02085005

22.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00642, 9604, 2013-0954, N01CM00039, P30CA016672, NCT02101918

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: R910-ST-1114, NCT01688960

24.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Mom1-AD12, 2012-005169-11, NCT01843725

25.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 120
Sponsor: NCI, Other
Protocol IDs: 13294, NCI-2013-01727, P30CA033572, NCT01941173
New Search